Immediate Impact
1 by Nobel laureates 57 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Works of Ying Di being referenced
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
2017
Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ying Di | 290 | 169 | 133 | 134 | 33 | 640 | |
| Tanawan Kummalue | 423 | 115 | 184 | 101 | 37 | 698 | |
| Albert Hagelgans | 361 | 98 | 76 | 53 | 27 | 639 | |
| Yousef M. Hawsawi | 291 | 123 | 62 | 110 | 46 | 645 | |
| Yu Liu | 262 | 140 | 85 | 46 | 52 | 644 | |
| Carlos Román | 315 | 70 | 177 | 190 | 40 | 659 | |
| Rauf Onur Ek | 147 | 119 | 83 | 48 | 32 | 513 | |
| Yasufumi IMAI | 280 | 128 | 108 | 38 | 39 | 539 | |
| Yun Zhou | 351 | 80 | 106 | 42 | 43 | 602 | |
| Satu Koskela | 171 | 69 | 134 | 77 | 39 | 539 | |
| Daisuke Shima | 268 | 72 | 95 | 58 | 27 | 578 |
All Works
Login with ORCID to disown or claim papers
Loading papers...